Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting aging man. Attempts have been made to clarify the etiology and pathogenesis and, to that end, experimental models have been developed. To date, in vitro and in vivo models have been used, depending on the concept of the study. Spontaneous animal models are limited to the chimpanzee and the dog. Ethical and ®nancial factors restrict the applicability of these models. The hormonalinduced canine BPH model is a good alternative that closely resembles human BPH in many aspects. The experimental models currently used for studying BPH are reviewed. Prostate Cancer and Prostatic Diseases (2000) 3, 28±33.
Introduction
Benign prostatic hyperplasia (BPH) is a common disease in older men. It has a high public health impact and is one of the most common reasons for surgical intervention among elderly men. 1 Anatomic or microscopic evidence of BPH is present at autopsy in approximately 55% of men aged 60 ± 70 y. 2 Many attempts have been made during the last decade to obtain a thorough understanding of the what, why and how of BPH, but in spite of this the etiology and pathophysiology of the disease remain obscure. Transurethal resection has been the treatment of choice for many years. Recently, less invasive therapies such as laser prostatectomy, 3 ± 8 thermotherapy, 9 ± 15 and complementary medications 16 ± 18 have been introduced. Non-surgical modes of treatment have been studied intensively in order to ®nd satisfactory and cost-effective therapeutic options for patients in which surgical intervention carries a high risk. This might in the future cause a lack of human BPH tissues with which to study BPH. The dif®culties in obtaining long-term follow-up data as well as follow-up biopsy tissues motivate the transferral of studies from patients to animal models. Spontaneous BPH is rare in species other than man. It has only been described in the dog and recently also in chimpanzees. 19 Alternatives to the study of spontaneous disease in other species are induced BPH, xenografts and in vitro models. The purpose of this study is to review the currently available in vitro and in vivo models for studying BPH.
In vitro models
Cultures of normal prostate epithelial cells under conditions affecting their growth and differentiation offer useful in vitro model systems for studying the mechanisms of prostate cell function and regulation, as well as cellular transformation. Epithelial cells cultured from normal human prostates and from prostatectomy specimens from patients with BPH have presented the researchers with an alternative. 20 ± 22 The purity of epithelial cell cultures partly depends upon the source of tissue.
Specimens derived from open prostatectomies provided primarily pure epithelial cell cultures with occasional ®broblast colonies in some cultures, which could be removed. 20 Specimens from transurethral resection of the prostate contained many ®broblast colonies due to incomplete separation of acini from the stroma. 20 These epithelial cells can be serially passaged at least several times under proper culture conditions. The addition of cholera toxin to the growth medium was found to be important for the propagation of the culture. 22 In general, techniques for primary human cell culture require either multicomponent media 23, 24 or extensive periods of digestion. 25 The base media commonly contained cholera toxin, bovine pituitary extract, retinoic acid and insulin. Pituitary extract contains many hormones and growth factors. Krill and colleagues reported a simple, rapid and reproducible technique for the isolation and culture of prostate stromal or epithelial cells because the growthenhancing property of the culture could be achieved in the absence of unde®ned exogenous factors. 26 They showed that primary cultured prostate cells could undergo three to four passages before became senescent. The peak of proliferation of the phenotypically basal cell monolayer outgrowth from a BPH explant occurred after 2 ± 4 days in culture. 27 Stromal cell cultures have been studied intensively. Smooth muscle cells (SMCs) constitute a major cellular component of prostatic stroma. SMC tension can play an important role in urethral obstruction secondary to BPH. These stromal cell/SMC cultures maintain the cellular and functional properties of the human prostate, such as sensitivity to steroid hormones and androgen receptor mRNA expression. 28 ± 30 An essential part of normal gland development and function appears to be the complex interaction between epithelium and stroma. 31, 32 Bayne et al 33 developed a coculture system for primary ®broblasts and epithelial cells that retained the expressions of messenger ribonucleic acid, androgen receptors and prostate-speci®c antigen (PSA), as well as maintaining functional activity for both isoenzymes of 5 alpha-reductase (type I and type II). In addition, cocultured epithelial cells secreted higher levels of PSA after androgen treatment. These more closely resembled the in vivo system for human BPH and are thus a more suitable model for investigating the molecular and cellular events that underlie BPH than are current in vitro systems.
Most of the available human prostate cell lines are derived from malignancies and hence are not suitable for studying normal prostate physiology or the initiation and development of tumors. To date a limited number of prostate cell lines are known to be nontumorigenic. Epithelial cell lines NRP-152 and NRP-154 have been derived from the prostate of Lobund/Wistar rats and can be used for analysis of normal prostate growth and prostatic carcinogenesis, respectively. 34 In canine prostate epithelial cells, the attachment and spreading of cells in monolayers were mediated by nonsteroidal factors present in dialyzed fetal bovine serum and in the natural extracellular matrices. The presence of these factors, together with steroids, did not elicit a proliferative response to steroids nor did they increase the effect of growth-promoting factors in dog serum. 35, 36 Recently, Lehr et al 37 reported the isolation of canine prostate epithelial cells from a sexually intact, adult beagle. Epithelial clones were immortalized by tranfection with the Simian Virus 40 large T-antigen cDNA. This cell line can be an alternate choice for cell lines derived from man or rats for studying BPH.
In vivo models
In order to study the biological behavior of tumor growth and to test new therapeutic approaches, several in vivo models have been developed.
Xenograft models
Xenograft models of human BPH have been established and used for the investigation of the etiology of BPH, 38 ± 40 as well as the therapy of the disease. 41 Cells derived from human tissue culture and primary surgical specimens were transplanted into athymic rats or mice. Transplants displayed histologically typical BPH acini and stroma. They were maintained without signs of atrophy for up to 6 weeks and were preserved subcutaneously in Beige mice for up to 16 weeks. 42 The epithelial lining of the implants consistently expressed prostatic biomarkers PSA and prostate acid phosphatase. 38, 42 However, additional stimuli may be required for sustained growth of these implants in long-term carcinogenesis studies. Equivocal data have been reported on the effect of dihydrotestosterone on the growth of tissue implants. 38, 41, 42 Transgenic mice Transgenic mice are used as a model to study the consequence of various transforming events on the prostate gland. Several prostate-speci®c regulatory elements have been evaluated for their ability to direct heterologous gene expression speci®cally and reproducibly to the prostate in transgenic mice. Muller et al 43 have established transgenic mice which carry the int-2 gene driven by the murine mammary tumor virus (MMTV) promoter/ enhancer, TG.NR transgenic line. Int-2 (otherwise known as fgf3), a member of the ®broblast growth factor family of genes, can be activated by the MMTV long terminal repeat. Expression of the MMTV-int-2 transgene in the prostate results in an enlargement of the gland which, histologically, is a dramatic epithelial glandular and cystic hyperplasia similar to the glandular hyperplasia observed in the dog and resembling glandular BPH in man. However, the ®bromuscular stromal hyperplasia which is commonly seen in human BPH was not observed. In 1992, a patent was issued for Harvard II, a Harvard-developed mouse model for prostate enlargement. 44 This model was documented as being hormonally sensitive and suitable for investigating BPH and growth-factor-induced epithelial cell hyperplasia. 45 Kitsberg and Leder 46 found a common signaling pathway, the MMTV-kgf(fgf7)-induced hyperplasia that had the morphologic characteristics of that seen in MMTVint-2 mice. In the same way, Wennbo and his team 47 addressed the question whether overexpression of prolactin (PRL) is of importance for the development of prostatic hyperplasia. The PRL-transgenic mice developed a 4 ± 5-fold increase of the number of cells and enlagement of the prostate gland to 20 times the normal weight. The histological ®ndings of the PRL-transgenic mice resembled those in human BPH, in which the hyperplasia mainly involves connective tissue. In vivo, the speci®c relationship between insulin-like growth factor-I (IGF-I) and prostate development is dif®cult to determine. Ruan et al 48 recently used IGF-I null and growth hormone (GH) antagonist transgenic mice for these investigations. The results indicated that IGF-I de®ciency caused an impairment of prostate development, and that IGF-I and GH might be as an extension of normal processes involved in prostatic neoplasia. 48 
BPH induction
Rat and mice prostates have been documented to respond to hormone and chemical carcinogen treatment. However, only the dorsolateral lobe of the rodent prostate is ontogenetically comparable to the human prostate. 49 In the rat, the strain genotype plays a determinative role in prostatic responsiveness. Scolnik et al 50 developed an experimental model for the study of rat prostatic hyperplasia and/or dysplasia induced by citral, a¯avor constituent. They found that the Wistar and Sprague Ð Dawley strains were most susceptible to developing benign and atypical prostatic hyperplasia after treatment with exogenous testosterone in both intact and postcastrated males. The F344 and ACl/Ztm rats were refractory. 50 In Sprague ± Dawley rats, treatment with DHT and estradiol caused growth of the ventral prostate. 51 Lee et al 52 developed a model for the study of the development of urinary tract obstruction by using neurohormonally stimulated prostate growth in the rat. In this model, prostate growth was induced by the combined administration of dihydrotestosterone (DHT) (1.25 mg/ kg/day) and the alpha-1 adrenoreceptor antagonist prazosin, 30 mg/kg/day subcutaneously for 14 days. Based on the observation that fetal and adult prostatic cells interact to induce the proliferation of adult prostatic cells, a mouse prostate reconstitution (MPR) model was developed by Chung et al. 53 BPH was induced by using direct implantation of tissue of fetal urogenital sinus (UGS) or its mesenchyme (UGM) into the prostate gland in situ. These fetal inductors were proven to act as growth-promoting substances for mouse prostate. Histologic analysis revealed that the UGS implants induced marked prostatic epithelial proliferation in the complete absence of exogenous sex steroids, 53 but initiation and maintenance of hyperplasia required testicular androgens. 54, 55 This model represents the basis for a uni®ed hypothesis regarding the roles of tissue interaction and hormonal milieu in human BPH and may be used as a test system for the development of future anti-BPH drugs.
To date, it is uncertain whether the rodent models can simulate the human prostate disease, since murine and human prostates differ markedly: spontaneous BPH is absent in the mouse prostate (in fact, its prostate becomes atrophic with advancing age) 56 and the rodent prostate consists of three lobes, the ventral, dorsolateral and anterior lobes, which are con®ned to the urethra. In man, four distinct regions of different tissue composition have been described. These are the anterior ®bromuscular stroma and the central, peripheral, and transitional zones. 57 In addition to rodent models, dogs have been used for the study of human BPH. BPH in man and the dog has many features in common. In both species the development of BPH occurs spontaneously with advanced age and can be prevented by early/prepubertal castration. The prostatic epithelial hyperplasia in both man and the dog is androgen sensitive, undergoing involution with androgen deprivation and resuming epithelial hyperplasia when androgen is replaced. 45 Walsh and Wilson 58 have developed a model in which BPH is induced in castrated dogs by the long-term administration of 5a-androstane-3a, 17b-diol (3a-diol), 75 mg/week, in combination with 17b-estradiol, 0.75 mg/week. 3a-Diol is formed by 3a reduction of DHT and/or 17b reduction of androsterone and was reported to be a potent agonist of the human and canine prostatic sex-hormone binding globulin receptor by stimulating intracellular cAMP in the prostate. In addition, estradiol was found to be the only other agonist in this system. 59 The histological characteristics of the hyperplasia resembles the glandular form of spontaneous canine disease. However, squamous metaplasia was observed if the ratio of 5a-reduced androgen to estrogen was less than 100. 60 Several regimes have been developed to induced BPH in dogs (Table 1) .
Administration of either testosterone or DHT alone or testosterone plus estradiol to castrated dogs increased prostatic weight but did not result in the histomorphological features observed in BPH. 61 In contrast to that in man, the enlarged prostate in the dog rarely results in urethral obstruction. 62 Broderick et al 63 developed a canine model of BPH that will secondarily result in partial urethral obstruction and impaired urodynamics. The prostate was encapsulated in a nylon mesh to prevent its enlargement into the peritoneal cavity and then the dog was treated with steroids to induce prostate growth. Urethral obstruction resembling that in human BPH could be reproduced with this model.
Spontaneous BPH
Naturally occurring animal models for human BPH offer advantages over other models but are limited to a few species. Other than in man, spontaneous BPH is only observed in dogs and chimpanzees. 19 In these animals, BPH is also an age-related disease. The onset of BPH in the dog may occur at as early as 2 ± 3 y of age, 61 but it occurs with high frequency in aged dogs. 64, 65 Microscopic BPH was observed in all dogs after 6 y of age. 65 There are, however, important differences between human and canine prostatic anatomy and histology. In human beings, there are clearly de®ned zones in the prostate. The human prostate is anatomically ®xed between the symphysis pubis and the rectum. Hyperplastic growth compresses inwardly on the urethra, producing urinary Benign prostatic hyperplasia W Mahapokai et al obstruction. The clinical symtoms of BPH in humans may be due not only to age-related increases in prostate size, but also to the unique anatomic structure of the gland. 66 The disease is often a multinodular process thought to arise as periurethral stromal nodules which are then invaded by glandular elements. 61 In man, PSA is produced only by epithelial cells and is found in normal, hyperplastic and malignant prostatic tissue. Serum PSA concentrations have been used to evaluate prostate volume in man. In contrast, the canine prostate is not anatomically ®xed and is not subdivided into regions. Hyperplastic growth expands outwardly in all directions, producing rectal compression and constipation. Symptoms of prostatism rarely arise because the canine gland lacks a capsule. 66 Most dogs with BPH have no clinical signs and only in some dogs does the enlarged prostate cause clinical signs such as micturation problems, defecation abnormalities, or pain in the hind quarters. 62 An intermittent hemorrhagic urethral discharge or intermittent or persistent hematuria is more common. Canine BPH is uniform and diffuse, occurring thoughout the entire gland and it primarily involves the glandular epithelial cells, with less stromal involvement. 45, 61, 65, 67, 68 Tunn and his colleagues 69 reported that the concentration of 5a-reductase, which converts testosterone to dihydrotestosterone, an active androgen, is higher in the prostatic epithelium than in the stroma in dogs. This is not the case in man which may explain why the hyperplasia is mainly epithelial in dogs and stromal in men. Furthermore, PSA was not detected in canine serum or seminal plasma from either normal dogs or dogs with BPH, 70 although it has been identi®ed in normal, neoplastic and hyperplastic canine prostatic epithelial cells. 71 However, canine prostate-speci®c esterase, the major secretory product of the canine prostate, increased in serum from dogs with BPH. 70 This protein and PSA are distinctly different but functionally related proteins. 72 Despite the differences, the natural cause of hyperplasia is remarkably similar in the two species. In general, functional testes presumably stimulate prostatic growth with advancing age, although they appear to be nonspeci®c. 73 A number of investigators have used this spontaneous model to study the etiology 61,74 ± 76 and the effect of chemopreventive agents and medical therapy 77 ± 87 in BPH. Unfortunately, a lack of commercially available aged male dogs makes this model dif®cult to use.
Spontaneous BPH also occurs in nonhuman primates. The ®rst systematic study of prostatic tissues in nonhuman primates was performed by Lewis et al. 88 In their study, glandular hyperplasia was found in 13 of 100 nonhuman primates representing 12 species, but the age of many of these animals was not documented. Recently, a report by Steiner et al 19 revealed for the ®rst time that the chimpanzee is a perfect animal model for studying human BPH. The authors have studied the occurrence of spontaneous BPH in a colony by assessing pathological and clinical factors including prostate volume, serum PSA, the histological presence of BPH, serum androgens and estradiol, and urodynamic parameters. The chimpanzee's prostate is anatomically and physiologically similar to that of man. Spontaneous BPH in this species increased in incidence with age. It caused enlargement of the prostate, a higher stromal/epithelial ratio, higher serum PSA, and a decreased urinary¯ow rate, all similar to what occurs in human BPH, but serum hormone levels were not found to be related to BPH.
Discussion
The pathogenesis of BPH remains very elusive. Several animal models have been developed for studying BPH. In vitro models appear to be useful for studying the mechanisms of cell function and regulation, as well as cellular transformation. The obvious advantage is the possibility of well-controlled studies using soluble and insoluble factors affecting the growth of prostatic epithelium, which are dif®cult to investigate in vivo. The clinical signi®cance of results obtained from the experimental in vitro models, however, needs to be substantiated. The relevance of in vitro studies will only be established if the normal response patterns and function of cells are well preserved when they are separated from their in vivo environment. Transgenic and xenograft models are the alternative choices, which can be useful in certain studies. Transgenic models can provide insight into the effects of individual oncogenes on cellular transformation, differentiation and viability. The short-term effect of some factors on transplanted tissue can be evaluated using xenograft models.
Spontaneous BPH occurs only in humans, dogs and chimpanzees. To study the pathogenesis of human BPH, spontaneous models and hormonal-induced BPH are more suitable models. Spontaneous models would be a valuable tool if the prevalence is suf®ciently high, but the ethical and ®nancial matters need to be considered. Currently, the chimpanzee model is the most representative animal model for human BPH. However, the limited availability of this animal for studying BPH makes this a less practicable model. Moreover, only one study has been published and con®rmation of the ®ndings is needed. The canine model has been widely used and is suitable for investigating many aspects of abnormal prostate growth related to BPH. Hormonal-induced BPH in the dog is a more readily available and less expensive model than the spontaneous models and is a good alternative in the study of human BPH. One should, however, be aware of the differences between the species.
